Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Cell Cancer Registry in Latin American Clinical-phatological Characterization and Outcomes of Renal Cell Carcinoma in Latin America

NCT05184504 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.

NCT NCT05184504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05184504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Cell Cancer Registry in Latin American Clinical-phatological Characterization and Outcomes of Renal Cell Carcinoma in Latin America
Lead sponsor
Latin American Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
July 11, 2024
Enrollment
211 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

kidney neoplasms